Next, for in vivo analysis the C57BL/6 mice with subcutaneously injected murine melanoma B16-F10 were treated by adoptively transferring gp100 TCR reactive T cells, which were either pre-treated with NecroX2 or not (Figure 5B). The gene discussed is PMEL; the disease is melanoma.